Helix Acquisition Corp Ii (HLXB)

Jun 05, 2025

Toronto Dominion Bank Takes $520,000 Position in Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat

Jun 05, 2025

May 30, 2025

Toronto Dominion Bank Invests $520,000 in Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat

May 30, 2025

May 22, 2025

Big Law Firms Wary of SPAC Rebound Seek to Get Paid This Time - Bloomberg Law News

May 22, 2025

May 20, 2025

Helix BioPharma Expands Oncology Portfolio with Strategic Acquisition - TipRanks

May 20, 2025

May 20, 2025

Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA(TM) and GEMCEDA(TM) in Strategic Acquisition from the Laevoroc Group - TheNewswire

May 20, 2025

May 15, 2025

Helix Acquisition Corp. II SEC 10-Q Report - TradingView

May 15, 2025

May 05, 2025

Geode Capital Management LLC Acquires 119,943 Shares of Nuburu, Inc. (NYSEAMERICAN:BURU) - Defense World

May 05, 2025

May 05, 2025

Geode Capital Management LLC Acquires 16,862 Shares of Estrella Immunopharma, Inc. (NASDAQ:ESLA) - Defense World

May 05, 2025

May 05, 2025

Geode Capital Management LLC Increases Stock Holdings in Helix Acquisition Corp. II (NASDAQ:HLXB) - Defense World

May 05, 2025

May 05, 2025

Crown Castle (NYSE:CCI) Upgraded at New Street Research - Defense World

May 05, 2025

May 05, 2025

National Bank Financial Predicts Cameco FY2026 Earnings - Defense World

May 05, 2025

May 04, 2025

DaVita Inc. (NYSE:DVA) Given Consensus Rating of “Hold” by Brokerages - Defense World

May 04, 2025

May 04, 2025

CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 04, 2025

Apr 23, 2025

Swiss ADC Biotech Takes SPAC Track to NASDAQ - BioSpace

Apr 23, 2025

Apr 23, 2025

German cancer antibody biotech eyes SPAC as route to Nasdaq - Fierce Biotech

Apr 23, 2025

Apr 23, 2025

Harraden Circle Investments LLC Acquires Shares of 257,226 Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat

Apr 23, 2025

Apr 10, 2025

Helix BioPharma Corp. Appoints Dr. Thomas Mehrling as Chief Executive Officer to Drive Ambitious Clinical Development Plan - Yahoo Finance

Apr 10, 2025

Apr 01, 2025

MLTX stock touches 52-week low at $36.51 amid market shifts - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

MLTX stock touches 52-week low at $36.51 amid market shifts By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors - Business Wire

Apr 01, 2025

Mar 27, 2025

Firm foundations: Can US IPO markets continue to build on solid gains? - Lexology

Mar 27, 2025

Mar 23, 2025

Decagon Asset Management LLP Invests $1.96 Million in Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat

Mar 23, 2025

Mar 20, 2025

Newsroom - White & Case LLP

Mar 20, 2025

Mar 18, 2025

GSK’s $1.15B Idrx buyout leads slow M&A market as deals stay strong - BioWorld Online

Mar 18, 2025

Mar 14, 2025

Bay Area VC-funded life sciences companies raised over $5 billion in 2024 - The Business Journals

Mar 14, 2025

Mar 12, 2025

Helix Exploration expands with key acquisition at Rudyard - Proactive Investors

Mar 12, 2025

Mar 11, 2025

Helix Acquisition Corp. II SEC 10-K Report - TradingView

Mar 11, 2025

Mar 10, 2025

MLTX stock touches 52-week low at $37.53 amid market shifts - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

BBIOBridgebio Pharma Latest Stock News & Market Updates - StockTitan

Mar 10, 2025

Mar 06, 2025

Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics - Global Legal Chronicle

Mar 06, 2025

Mar 04, 2025

BridgeBio Oncology and Helix enter definitive merger agreement - MSN

Mar 04, 2025

Mar 03, 2025

BridgeBio spin-out in SPAC deal to target RAS and PI3Kα malignancies - The Pharma Letter

Mar 03, 2025

Mar 03, 2025

White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics - White & Case LLP

Mar 03, 2025

Feb 28, 2025

Helix Acquisition Corp. II (HLXB) to Combine with BridgeBio Oncology in $360M Deal - SPACInsider

Feb 28, 2025

Feb 28, 2025

Helix Acquisition Corp. II Merger with BridgeBio Oncology Therapeutics - Leerink Partners

Feb 28, 2025

Feb 28, 2025

Helix Acquisition Corp. II PIPE - Leerink Partners

Feb 28, 2025

Feb 28, 2025

Finance Watch: BridgeBio’s Oncology Spinout Reveals Go-Public Plan - insights.citeline.com

Feb 28, 2025

Feb 28, 2025

LZ Technology Closes $7.2 Million IPO -February 28, 2025 at 04:48 pm EST - Marketscreener.com

Feb 28, 2025

Feb 28, 2025

BridgeBio spinout to go public in SPAC deal with Helix Acquisition Corp. II - MSN

Feb 28, 2025

Feb 28, 2025

BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs - MedCity News

Feb 28, 2025

Feb 28, 2025

Boston SPAC picks biotech to take public - The Business Journals

Feb 28, 2025

Feb 28, 2025

Goodwin, White & Case Build BridgeBio's $949M SPAC Deal - Law360

Feb 28, 2025

Feb 28, 2025

BridgeBio oncology spinout to go public in blank-check merger - BioPharma Dive

Feb 28, 2025

Feb 28, 2025

BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal - BioSpace

Feb 28, 2025

Feb 28, 2025

Helix Acquisition to Merge With BridgeBio Oncology Therapeutics - MarketScreener

Feb 28, 2025

Feb 28, 2025

BridgeBio's KRAS-focused cancer spinout backs SPAC as path to Nasdaq - Fierce Biotech

Feb 28, 2025

Feb 28, 2025

BridgeBio Oncology Therapeutics and Helix Acquisition Corp. II To Merge - citybiz

Feb 28, 2025